KR960033456A - Antistress Pharmaceutical Composition - Google Patents
Antistress Pharmaceutical Composition Download PDFInfo
- Publication number
- KR960033456A KR960033456A KR1019950006225A KR19950006225A KR960033456A KR 960033456 A KR960033456 A KR 960033456A KR 1019950006225 A KR1019950006225 A KR 1019950006225A KR 19950006225 A KR19950006225 A KR 19950006225A KR 960033456 A KR960033456 A KR 960033456A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- pharmaceutical composition
- composition according
- choline acids
- choline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 콜린산류의 스트레스 예방 및 치료용 용도와 그의 약제조성물에 관한 것으로, 콜린산류로는 우루소데옥시콜린산, 타우로우루소데옥시콜린산, 체노데옥시콜린산, 디하이드로콜린산 또는 동물의 담즙중에서 선택되며, 이들을 주성분으로 하고 여기에 약제학적으로 허용가능한 담체로서 희석제, 활택제, 결합제, 붕해제, 감미제, 안정제, 방부제중에서 1종 또는 2종 이상을 선택하여 사용하고, 첨가제로서 향료, 비타민류, 항산 화제중에서 1종 또는 2종 이상을 선택, 사용하여 정제, 캅셀제, 연질캅셀제, 액제, 산제 등의 형태로 제형화한것이다.The present invention relates to the use of choline acids for the prevention and treatment of stress and pharmaceutical compositions thereof, and the choline acids include urosodeoxycholine acid, taurousodeoxycholine acid, chenodeoxycholine acid, dihydrocholine acid or It is selected from the bile of the animal, which is used as a main ingredient and one or two or more selected from diluents, lubricants, binders, disintegrants, sweeteners, stabilizers, preservatives as a pharmaceutically acceptable carrier. It is formulated in the form of tablets, capsules, soft capsules, liquids, powders, etc. by using one or two or more selected from fragrances, vitamins and antioxidants.
콜린산류는 1일 복용량은 5∼800mg 되도록하여 분복한다.Choline acids are divided into 5 to 800 mg daily doses.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950006225A KR0155976B1 (en) | 1995-03-23 | 1995-03-23 | Anti-stress pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950006225A KR0155976B1 (en) | 1995-03-23 | 1995-03-23 | Anti-stress pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960033456A true KR960033456A (en) | 1996-10-22 |
KR0155976B1 KR0155976B1 (en) | 1998-11-16 |
Family
ID=19410435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950006225A KR0155976B1 (en) | 1995-03-23 | 1995-03-23 | Anti-stress pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0155976B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106804485B (en) * | 2017-03-21 | 2019-12-17 | 中国水产科学研究院淡水渔业研究中心 | Stress-resistant method for temporarily culturing coilia ectenes in small water body |
-
1995
- 1995-03-23 KR KR1019950006225A patent/KR0155976B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR0155976B1 (en) | 1998-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9611802A (en) | Pharmaceutical compositions | |
HUP9901144A2 (en) | Pharmaceutical compositions containing new associations of clopidogrel and an antithrombotic agent | |
KR950007859A (en) | Rapamycin formulations for oral administration | |
YU13695A (en) | Application of 2-phenyl-3-aroylbenzothiophene and pharmaceutical formulations thereof | |
ATE148630T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING STABILIZED DERIVATIVES OF VITAMIN D2 AND D3 | |
KR940018089A (en) | Prevention and treatment for radiation damage of internal tissue | |
IT1187687B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENTS FLAVANOLIGNANI AND PHOSPHOLIPIDS | |
IT1263840B (en) | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES | |
IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
DE60002126D1 (en) | Substituted dimeric carboxamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
KR950007857A (en) | Rapamycin preparations for oral administration | |
KR970032872A (en) | Drugs for the treatment of skin damage containing acetylsalicylic acid | |
KR890001564A (en) | Pharmaceutical dosage unit | |
DE3263832D1 (en) | Gallium chloride, an anti-cancer drug | |
KR960033456A (en) | Antistress Pharmaceutical Composition | |
DE3883208D1 (en) | AGENTS FOR TREATING KERATOSIS. | |
ATE285782T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ALKYLARYL POLYETHER ALCOHOL POLYMER | |
KR960033455A (en) | Anticancer composition | |
DE69902925D1 (en) | New injectable medicinal preparations containing ramoplan | |
KR950016756A (en) | Fatigue Recovery Composition | |
KR950016755A (en) | Pharmaceutical composition for the prevention and treatment of hepatitis | |
PT100526A (en) | CHEMOTHERAPEUTIC AGENTS OF PLANT ORIGIN WITH ANTINEOPLASTIC ACTIVITY, POSSESSING HIGH SELECTIVITY AND VERY REDUCED TOXICITY AND PROCESS FOR THEIR PREPARATION | |
GB2082910A (en) | Anti-depressant compositions | |
KR950016757A (en) | Drug addiction therapeutic composition | |
KR910002455A (en) | Pharmaceutical compositions containing acrylic acid derivatives and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 17 |
|
EXPY | Expiration of term |